Isofol Medical Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Isofol Medical.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 49.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
We're Interested To See How Isofol Medical (STO:ISOFOL) Uses Its Cash Hoard To Grow
Jul 12
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued
May 18Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation
Nov 09Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?
May 12Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)
Apr 08Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment
Mar 03We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully
Jan 10
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Isofol Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 0 | -35 | -39 | -39 | N/A |
| 3/31/2024 | 0 | -35 | -46 | -46 | N/A |
| 12/31/2023 | 1 | -37 | -53 | -53 | N/A |
| 9/30/2023 | 3 | -53 | -88 | -88 | N/A |
| 6/30/2023 | 5 | -80 | -120 | -120 | N/A |
| 3/31/2023 | 9 | -120 | -155 | -155 | N/A |
| 12/31/2022 | 13 | -160 | -193 | -193 | N/A |
| 9/30/2022 | 16 | -196 | -190 | -190 | N/A |
| 6/30/2022 | 18 | -214 | -209 | -209 | N/A |
| 3/31/2022 | 21 | -209 | -201 | -201 | N/A |
| 12/31/2021 | 22 | -200 | -188 | -188 | N/A |
| 9/30/2021 | 36 | -194 | -182 | -182 | N/A |
| 6/30/2021 | 50 | -173 | -148 | -148 | N/A |
| 3/31/2021 | 42 | -176 | -142 | -142 | N/A |
| 12/31/2020 | 37 | -189 | -160 | -160 | N/A |
| 9/30/2020 | 18 | -192 | -186 | -186 | N/A |
| 6/30/2020 | N/A | -204 | -183 | -183 | N/A |
| 3/31/2020 | N/A | -191 | -176 | -176 | N/A |
| 12/31/2019 | N/A | -162 | -148 | -147 | N/A |
| 9/30/2019 | N/A | -133 | -106 | -105 | N/A |
| 6/30/2019 | N/A | -108 | -101 | -101 | N/A |
| 3/31/2019 | N/A | -90 | -96 | -96 | N/A |
| 12/31/2018 | N/A | -83 | -92 | -92 | N/A |
| 9/30/2018 | 0 | -80 | -90 | -90 | N/A |
| 6/30/2018 | 0 | -82 | -86 | -86 | N/A |
| 3/31/2018 | 0 | -79 | N/A | -73 | N/A |
| 12/31/2017 | 0 | -72 | N/A | -62 | N/A |
| 9/30/2017 | 0 | -77 | N/A | -57 | N/A |
| 6/30/2017 | 0 | -66 | N/A | -47 | N/A |
| 3/31/2017 | 0 | -63 | N/A | -46 | N/A |
| 12/31/2016 | 1 | -65 | N/A | -47 | N/A |
| 12/31/2015 | 0 | -41 | N/A | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ISOFOL's forecast earnings growth is above the savings rate (1.2%).
Earnings vs Market: Insufficient data to determine if ISOFOL's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if ISOFOL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ISOFOL's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if ISOFOL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ISOFOL's Return on Equity is forecast to be high in 3 years time